Hikma Pharmaceuticals (HIK) Stock Chart & Stock Price History GBX 1,891 -16.00 (-0.84%) As of 11:55 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock Hikma Pharmaceuticals Stock Price Performance 5 Day Performance+3.33%1 Month Performance-6.01%3 Month Performance-8.67%6 Month Performance-5.54%Year-To-Date Performance-5.59%1 Year Performance+6.32% Receive HIK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HIK Stock Chart for Wednesday, April, 16, 2025 HIK Chart by TradingViewRemove Ads Hikma Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/15/2025GBX 1,851.65GBX 1,906.41+2.96%GBX 1,914GBX 1,873501,934 shs£5.29 billion04/14/2025GBX 1,830GBX 1,851.65+1.18%GBX 1,876GBX 1,83218.67 million shs£5.13 billion04/11/2025GBX 1,848GBX 1,830-0.97%GBX 1,859GBX 1,813464,955 shs£5.07 billion04/10/2025GBX 1,774GBX 1,848+4.17%GBX 1,921GBX 1,84459.71 million shs£5.12 billion04/09/2025GBX 1,841GBX 1,774-3.64%GBX 1,810GBX 1,751963,074 shs£4.92 billion04/09/2025GBX 1,841GBX 1,774-3.64%GBX 1,810GBX 1,751963,074 shs£4.92 billion04/08/2025GBX 1,788GBX 1,841+2.96%GBX 1,851GBX 1,793552,782 shs£5.11 billion04/08/2025GBX 1,788GBX 1,841+2.96%GBX 1,851GBX 1,793552,782 shs£5.11 billion04/07/2025GBX 1,877GBX 1,788-4.74%GBX 1,866GBX 1,78024.25 million shs£4.96 billion04/04/2025GBX 1,955GBX 1,877-3.99%GBX 1,955GBX 1,853612,265 shs£5.21 billion Get the Latest News and Ratings for HIK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/03/2025GBX 1,937GBX 1,955+0.93%GBX 1,992GBX 1,919387,912 shs£5.42 billion04/02/2025GBX 1,961.24GBX 1,937-1.24%GBX 1,950GBX 1,903630,732 shs£5.37 billion04/01/2025GBX 1,949GBX 1,961.24+0.63%GBX 1,974GBX 1,948494,964 shs£5.44 billion03/31/2025GBX 1,967GBX 1,949-0.92%GBX 1,959GBX 1,930548,505 shs£5.40 billion03/28/2025GBX 1,997GBX 1,967-1.50%GBX 2,004GBX 1,967323,654 shs£5.45 billion03/27/2025GBX 2,018GBX 1,997-1.04%GBX 2,012GBX 1,97852.80 million shs£5.54 billion03/26/2025GBX 2,010GBX 2,018+0.40%GBX 2,026GBX 1,99452.94 million shs£5.60 billion03/25/2025GBX 1,986GBX 2,010+1.21%GBX 2,034GBX 1,97835.34 million shs£5.57 billion03/24/2025GBX 2,020GBX 1,986-1.68%GBX 2,030GBX 1,982424,880 shs£5.51 billion03/21/2025GBX 2,022GBX 2,020-0.10%GBX 2,028GBX 2,006971,943 shs£5.60 billion03/20/2025GBX 2,080GBX 2,022-2.79%GBX 2,050GBX 2,008645,549 shs£5.61 billion03/19/2025GBX 2,052GBX 2,080+1.36%GBX 2,090GBX 2,042515,383 shs£5.77 billion03/18/2025GBX 2,030GBX 2,052+1.08%GBX 2,062GBX 2,02076.30 million shs£5.69 billion03/17/2025GBX 2,012GBX 2,030+0.89%GBX 2,038GBX 1,994419,824 shs£5.63 billion Related Companies HUTCHMED Stock Price Chart Indivior Stock Price Chart Alliance Pharma Stock Price Chart Allergy Therapeutics Stock Price Chart Animalcare Group Stock Price Chart Venture Life Group Stock Price Chart ECO Animal Health Group Stock Price Chart Shield Therapeutics Stock Price Chart Provexis Stock Price Chart Argent BioPharma Stock Price Chart Receive HIK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HIK) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIK Stock Free HIK Stock Alerts